Effect of terbutaline on exercise capacity and pulmonary function in patients with chronic obstructive pulmonary disease

Lung

Volumn 177, Issue 4, 1999, Pages 263-271

  Iversen, E T ^a,c   Sorensen T ^a   Heckscher, T ^a   Jensen, J I ^b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

COPD; Energy expenditure; Exercise capacity; Lung function; Terbutaline

Indexed keywords

TERBUTALINE;

ADULT; AGED; ARTICLE; CARBON DIOXIDE TENSION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG FORMULATION; ENERGY EXPENDITURE; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; LUNG VENTILATION; MALE; METERED DOSE INHALER; MONITORING; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERMOGENESIS;

EID: 0032813668     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007646     Document Type: Article

References (18)

1. 1. Amoroso P, Wilson SR, Moxham J, Ponte J (1993) Acute effects of inhaled salbutamol on the metabolic rate of normal subjects. Thorax 48:882-885
2. 2. Beaver WL, Wasserman K, Whipp BJ (1986) A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 60:2020-2027
3. 3. Berger R, Smit D (1988) Effect of inhaled metaproterenol on exercise performance in patients with stable "fixed" airway obstruction. Am Rev Respir Dis 138:624-629
4. 4. Borgström L, Bondesson E, Morén F, Trofast E, Newman SP (1994) Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjects. Eur Resp J 7:69-73
5. 5. Borgström L, Newman S (1993) Total and regional lung deposition of terbutaline sulphate inhaled via pressurised MDI or via Turbuhaler. Int J Pharm 97:47-53
6. 6. Buchfuhrer MJ, Hansen JE, Robinson TE, Sue DY, Wassermann K, Whipp BJ (1983) Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol 55:1558-1564
7. 7. Burdet L, de Muralt B, Schutz Y, Fitting JW (1997) Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease. Thorax 52:130-135
8. 8. Cooper CB (1995) Determining the role of exercise in patients with chronic pulmonary disease. Med Sci Sports Exer 27:147-157
9. 9. Corris PA, Neville E, Nariman S, Gibson GJ (1983) Dose-response study of inhaled salbutamol powder in chronic airway obstruction. Thorax 38:292-296
10. 10. Dullinger D, Kronenberg R, Niewoehner DE (1986) Efficacy of inhaled metaproterenol and orally administered theophylline in patients with chronic airway obstruction. Chest 89:171-173
11. 1, FVC, dyspnea and walking distance in patients with chronic obstructive lung disease. Respir Med 86:93-96
12. 12. Guyatt GH, Townsend M, Pugsley SO, et al. (1987) Bronchodilators in chronic air-flow limitation. Am Rev Respir Dis 135:1069-1074
13. 13. Jenkins SC, Moxham J (1987) High dose salbutamol in chronic bronchitis: comparison of 400 μg, 1 mg, and 2 mg and placebo delivered by Rotahaler. Br J Dis Chest 81:242-247
14. 14. Lipworth BJ, Clark RA, Dhillon DP, McDevitt DG (1990) Comparison of the effects of prolonged treatment with low and high doses of terbutaline on β-adrenoceptor responsiveness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 142:338-342
15. 15. Maltbæk N, Garsdal P, Christensen H, et al. (1989) Effects of oral terbutaline in chronic airflow limitation. Chest 95:1248-1252
16. 16. Papiris S, Galavotti V, Sturani C (1986) Effects of β-agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Respiration 49:101-108
17. 17. Standardization of lung function test. (1983) Bull Eur Physiopathol Respir 19:Suppl 5
18. 18. Wassermann K, Hansen JE, Sue DY, Whipp BJ (1987) Principles of Exercise Testing and Interpretation. Lea & Febiger, Philadelphia